CD30 / TNFRSF8 (Hodgkin & Reed-Sternberg Cell Marker) Mouse Monoclonal Antibody

9007-83-4

[TNFRSF8]

943

Human

Store at 2 to 8 °C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

Recognizes a single chain glycoprotein of 105/120kDa, identified as CD30/Ki-1. CD30 is synthesized as a 90kDa precursor, which is processed in the Golgi complex into a membrane-bound phosphorylated mature 105/120kDa glycoprotein. In Hodgkin's disease, CD30/Ki-1 antigen is expressed by mononuclear-Hodgkin and multinucleated Reed-Sternberg cells. It is also expressed by the tumor cells of a majority of anaplastic large cell lymphomas as well as by a varying proportion of activated T and B cells. This MAb distinguishes large cell lymphomas derived from activated lymphoid cells from histiocytic malignancies and lymphomas derived from resting and precursor lymphoid cells or from anaplastic carcinomas. About one third of the Ki-1 positive lymphomas lack the leukocyte common antigen (CD45).

[TNFRSF8; TNFRSF8; CD30; Ki-1; D1S166E; CD30; D1S166E]

[CD30 / TNFRSF8]

[tumor necrosis factor receptor superfamily member 8 isoform 1; Tumor necrosis factor receptor superfamily member 8; tumor necrosis factor receptor superfamily member 8; TNF receptor superfamily member 8; CD30L receptor; Ki-1 antigen; Lymphocyte activation antigen CD30; CD_antigen: CD30]

597709795

NP_001234.3

NM_001243.4

P28908